Related Experiment Video
Updated: Jan 29, 2026
The Number e as a Limit
Published on: January 12, 2026
Declining hospital mortality in acute myocardial infarction
M Dellborg1, P Eriksson, M Riha
1Department of Medicine, University of Göteborg, Ostra Hospital, Sweden.
Insights
Combined cardiac treatments significantly reduced acute myocardial infarction mortality by nearly 40%. This improvement stems from the synergistic effect of multiple interventions, not a single drug, highlighting advancements in coronary care.
Area of Science:
- Cardiology
- Clinical Medicine
- Public Health
Background:
- Acute myocardial infarction (AMI) poses a significant mortality risk.
- Individual therapies like beta-blockers, nitrates, aspirin, and thrombolytics reduce AMI mortality.
- The combined impact of these treatments in routine coronary care was previously unassessed.
Purpose of the Study:
- To evaluate the effect of combined therapeutic interventions on in-hospital mortality in acute myocardial infarction.
- To assess trends in AMI mortality following the implementation of a multi-drug treatment protocol.
Main Methods:
- Retrospective analysis of a computerized database of AMI patients from 1979-1990.
- Introduction of routine intravenous beta-blockers (1984), intravenous nitroglycerin (1986), aspirin (1988), and thrombolytic therapy (1988) for eligible patients.
- Comparison of in-hospital mortality rates before and after the implementation of combined therapies.
Main Results:
- In-hospital mortality for AMI declined from 18.5% in 1979 to 11.8% in 1990 (P < 0.01).
- This represents an approximate 40% reduction in mortality over the study period.
- The decline occurred despite a similar patient cohort size and an increasing median patient age.
Conclusions:
- The combined use of multi-lead monitoring, early beta-blockers, nitroglycerin, aspirin, and thrombolytic agents significantly reduced AMI mortality.
- The observed mortality reduction is attributed to the synergistic effect of multiple therapeutic interventions.
- This study underscores the effectiveness of comprehensive, multi-faceted treatment strategies in improving outcomes for acute myocardial infarction patients.
Abstract:
Beta-blockers, nitrates, aspirin and thrombolytic drugs have each separately been shown to reduce mortality in acute myocardial infarction, but the effect of these treatments combined during routine coronary care has not been assessed. The coronary care unit at Ostra Hospital services a stable community of 250,000 inhabitants. Since 1984 all patients have been entered into a computerized database. In addition, information on age, sex, discharge diagnosis and hospital outcome is also available for patients admitted between 1979 and 1983. In 1984, routine treatment with intravenous beta-blockers was introduced, to be followed in 1986 by intravenous nitroglycerin and in 1988 by aspirin in all patients without contraindications. Since 1988, intravenous thrombolytic treatment has been also given routinely to all patients with ST-elevation and chest pain < 6 h. Despite a similar number of patients and an increasing median age, the in-hospital mortality has declined from 18.5% in 1979 to 11.8% in 1990 (P < 0.01). It is concluded that mortality from acute myocardial infarction has declined by almost 40% since 1979. This reduction cannot be explained by a single major therapeutic intervention but may be attributed to the combined use of multi-lead monitoring, early use of beta-blockers, nitroglycerin, aspirin and thrombolytic agents.
Related Concept Videos
The Number e as a Limit
Limits at Infinity
Introduction to Limits
Types of Limits I
Limit Laws I
Limiting Reactant